Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, today announced that it will effect a
Uxin Limited (Nasdaq: UXIN) today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares from one (1) ADS representing three (3) Class A ordinary shares to one (1) ADS representing thirty (30) Class A ordinary shares.
BEIJING, Oct. 08, 2022 (GLOBE NEWSWIRE) -- Missfresh Limited ("Missfresh" or the "Company") (NASDAQ:MF), an innovator in China's neighborhood retail industry, today announced that it plans to change the ratio of its
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central
Quanergy Systems, Inc., (NYSE:QNGY) (“Quanergy” or the “Company”) a leading provider of LiDAR sensors and smart 3D solutions, announced today that its Board of Directors has approved a reverse
Hippo Holdings Inc. (NYSE:HIPO), the home insurance group focused on proactive home protection, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State
The reverse stock split is expected to take place on November 1, 2022 at 5:01 p.m. Eastern Time (the "Effective Time"). At the Effective Time, every four issued and outstanding shares of the company's
Ra Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") announces that at its virtual Special Meeting of Stockholders held today, the Company's stockholders approved all three